Jason at IIATMS has expanded his writing roster recently, and one of his additions is Larry, a lawyer/executive with significant experience in all matters relating to HGH and PED testing. Last night he wrote an extensive and quite entertaining Q&A regarding HGH testing, use and effects that is must-read material for anyone who tries to talk intelligently about this kind of stuff on the interwebs. There’s masses of scientific information-made-accessible in the post, but since I’m a big apologist and everything, this quote stuck out at me:
It seems that when it comes to anti-doping, perception is more important
than reality. The players perceive that HGH is performance-enhancing.
The fans perceive that HGH is performance-enhancing. The anti-doping
forces believe that they have a foolproof test to catch the athletes
using HGH. IN ALL LIKELIHOOD, NONE OF THESE PERCEPTIONS ARE TRUE. Yet
the perceptions takes on lives of their own. It seems likely that
baseball WILL go forward with some kind of HGH testing. The only
question is when.
Put that together with all of the difficulty Larry points out regarding the creation and implementation of HGH tests and you quickly realize that the discussion about HGH use in baseball is really more about politics than it is about performance enhancement.
The Yankees appear to have moved on from free agent Manny Machado this winter, but could they be turning their attention to Rockies superstar Nolan Arenado? That’s the idea floated by Andy Martino of SNY, who hears that GM Brian Cashman has been involved in recent discussions concerning the third baseman. No official comments have been made to the press yet, though, and it’s not clear whether the Yankees would prefer to pursue Arenado prior to the 2019 season or partway through it.
The 27-year-old infielder earned his fourth consecutive All-Star nomination, Silver Slugger, and Gold Glove award in 2018 after slashing .297/.374/.561 with 38 home runs, a .935 OPS, and 5.7 fWAR across 673 plate appearances. There’s no question he’s provided immense value to Colorado’s lineup over the last half-decade, and his consistency and incredible power at the plate helped form the basis of the record $30 million arbitration figure he presented to the team last week. The Rockies countered at $24 million, however, and in doing so may have jeopardized their chances of convincing the infielder to forego free agency in 2020 and take a long-term deal instead.
Assuming he declines to negotiate an extension with the Rockies, Arenado’s decorated résumé and career-best 2018 numbers should attract plenty of interest around the league — a reality that could put considerable pressure on the Yankees (or any other interested party) to finesse a deal sooner rather than later. For now, the club is prepared to enter the 2019 season with hot-hitting third baseman Miguel Andújar, whom Martino speculates would be the “centerpiece” of any trade with Colorado.